eCQMs for 2020 Performance Period CMS2v9 CMS22v8 CMS50v8 CMS52v8 CMS56v8 CMS66v8 CMS68v9 CMS69v8 CMS74v9 CMS75v8 CMS82v7 CMS90v9 CMS117v8 CMS122v8 CMS124v8 CMS125v8 CMS127v8 CMS128v8 CMS129v9 CMS130v8 CMS131v8 CMS132v8 CMS133v8 CMS134v8 CMS135v8 CMS136v9 CMS137v8 CMS138v8 CMS139v8 CMS142v8 CMS143v8 CMS144v8 CMS145v8 CMS146v8 CMS147v9 CMS149v8 CMS153v8 CMS154v8 CMS155v8 CMS156v8 CMS157v8 CMS159v8 CMS160v8 CMS161v8 CMS165v8 CMS177v8 CMS249v2 CMS347v3 CMS349v2 CMS645v3 CMS771v1 CMS Measure ID CMS137v8 Version 8 NQF Number Not Applicable Measure Description Percentage of patients 13 years of age and older with a new episode of alcohol or other drug abuse or (AOD) dependence who received the following. Two rates are reported. a. Percentage of patients who initiated treatment including either an intervention or medication for the treatment of AOD abuse or dependence within 14 days of the diagnosis b. Percentage of patients who engaged in ongoing treatment including two additional interventions or a medication for the treatment of AOD abuse or dependence within 34 days of the initiation visit. For patients who initiated treatment with a medication, at least one of the two engagement events must be a treatment intervention. Initial Population Patients age 13 years of age and older who were diagnosed with a new episode of alcohol, opioid, or other drug abuse or dependency during a visit between January 1 and November 14 of the measurement period Denominator Statement Equals Initial Population Denominator Exclusions Patients with a previous active diagnosis of alcohol, opioid or other drug abuse or dependence in the 60 days prior to the first episode of alcohol or drug dependence Exclude patients whose hospice care overlaps the measurement period. Numerator Statement Numerator 1: Initiation of treatment includes either an intervention or medication for the treatment of AOD abuse or dependence within 14 days of the diagnosis Numerator 2: Engagement in ongoing treatment includes two additional interventions or a medication for the treatment of AOD abuse or dependence within 34 days of the initiation visit. For patients who initiated treatment with a medication, at least one of the two engagement events must be a treatment intervention (i.e., engagement for these members cannot be satisfied with medication treatment alone). Numerator Exclusions Not Applicable Denominator Exceptions None Measure Steward National Committee for Quality Assurance Domain Effective Clinical Care Previous Version CMS137v7 Measure Scoring Proportion Measure Type Process Improvement Notation Higher score indicates better quality Guidance The new episode of alcohol and other drug dependence should be the first episode of the measurement period that is not preceded in the 60 days prior by another episode of alcohol or other drug dependence. Quality ID 305 Meaningful Measure Prevention and Treatment of Opioid and Substance Use Disorders Specifications Attachment Size CMS137v8.html 72.79 KB CMS137v8.zip 77.67 KB CMS137v8-TRN.xlsx 22.53 KB Release Notes Header Updated eCQM version number. Measure Section: eCQM Version number Source of Change: Measure Lead Updated NQF number to 'Not Applicable.' Measure Section: NQF Number Source of Change: Standards Update Updated endorsed by field to 'None.' Measure Section: Endorsed By Source of Change: Standards Update Updated description statement to indicate Numerator 2 time period for follow-up changed from 30 days to 34 days to accommodate injectable medications and align with HEDIS parent measure. Measure Section: Description Source of Change: Measure Lead Updated description statement with addition to Numerator statement Pharmacotherapy (Patients who initiated treatment with a medication need two or more engagement events where only one can be a medication treatment event) to align with current guidelines and HEDIS parent measure. Measure Section: Description Source of Change: Measure Lead Updated copyright. Measure Section: Copyright Source of Change: Annual Update Updated rationale. Measure Section: Rationale Source of Change: Measure Lead Updated clinical recommendation statement. Measure Section: Clinical Recommendation Statement Source of Change: Measure Lead Updated references to align with American Psychological Association (APA) style. Measure Section: Reference Source of Change: Measure Lead Updated references. Measure Section: Reference Source of Change: Measure Lead Updated definition statement to between January 1 to November 14 (intake period) of the measurement period to align with the parent measure. Measure Section: Definition Source of Change: Measure Lead Updated initial population statement visit time to between January 1 to November 14 (intake period) of the measurement period to align with the parent measure. Measure Section: Initial Population Source of Change: Measure Lead Updated numerator statement with addition of Pharmacotherapy (Patients who initiated treatment with a medication need two or more engagement events where only one can be a medication treatment event) to align with current guidelines and HEDIS parent measure. Measure Section: Numerator Source of Change: Measure Lead Updated numerator statement with addition to Numerator 2 time period for follow-up from 30 days to 34 days to accommodate injectable medications and align with HEDIS parent measure. Measure Section: Numerator Source of Change: Measure Lead Updated parenthetical citations to align with American Psychological Association (APA) style. Measure Section: Multiple Sections Source of Change: Measure Lead Logic Added telehealth services to the 'Qualifying Encounters' define statement. Measure Section: Initial Population Source of Change: Measure Lead Revised the 'First Dependence Diagnosis' to constrain the intake period to between January 1 and November 14 (starts 47 days or more before end of measurement period) to align with HEDIS parent measure. Measure Section: Initial Population Source of Change: Measure Lead Added telehealth services as an option for dependence intervention to particular define statements included in the numerator. Measure Section: Numerator Source of Change: Measure Lead Added pharmacotherapy as an option for dependence treatment in the numerator to align with current guidelines. Measure Section: Numerator Source of Change: Measure Lead Changed the Quality Data Model (QDM) category for the Alcohol and Drug Dependence Treatment value set (2.16.840.1.113883.3.464.1003.106.12.1005) from 'Encounter' to 'Intervention' to align with QDM standards. Measure Section: Numerator Source of Change: Measure Lead Increased the time period for follow-up from 30 days to 34 days for all define statements included in the numerator. Measure Section: Numerator Source of Change: Measure Lead Updated the names of Clinical Quality Language (CQL) definitions, functions, and/or aliases for clarification and to align with CQL Style Guide. Measure Section: Definitions and Functions Source of Change: Standards Update Updated Clinical Quality Language (CQL) expression to conform with the HL7 Standard: Clinical Quality Language Specification, Release 1 STU 3 (CQL 1.3). Measure Section: Multiple Sections Source of Change: Standards Update Updated definitions and functions in the Measure Authoring Tool (MAT) Global Common Functions Library to align with standards changes, Clinical Quality Language (CQL) Style Guide, and to include two new functions related to calculating hospital stays. Measure Section: Multiple Sections Source of Change: Standards Update Updated version number of the Hospice Library (Hospice-2.0.000). Measure Section: Multiple Sections Source of Change: Measure Lead Updated version number of the Measure Authoring Tool (MAT) Global Common Functions Library (MATGlobalCommonFunctions-4.0.000). Measure Section: Multiple Sections Source of Change: Standards Update Value Set The VSAC is the source of truth for the value set content, please visit the VSAC for downloads of current value sets. Value set Psych Visit - Psychotherapy (2.16.840.1.113883.3.526.3.1496): Added SNOMED CT extensional value set (2.16.840.1.113883.3.526.2.1777) including 13 codes. Measure Section: Terminology Source of Change: Annual Update Value set Alcohol and Drug Dependence (2.16.840.1.113883.3.464.1003.106.12.1001): Added 84 SNOMED CT codes and deleted 12 SNOMED CT codes. Added 1 ICD-10-CM code (F12.23). Measure Section: Terminology Source of Change: Annual Update Value set Opiate Antagonists (2.16.840.1.113883.3.464.1003.198.12.1132): Added Opiate Antagonists. Measure Section: Terminology Source of Change: Annual Update Value set Telehealth Services (2.16.840.1.113883.3.464.1003.101.12.1031): Added Telehealth Services. Measure Section: Terminology Source of Change: Annual Update Direct reference code for Birth date (LOINC Code (21112-8)) now displayed in Human Readable. Measure Section: Terminology Source of Change: Annual Update Removed code system versions from direct reference codes. Please refer to Appendix A of the Electronic Clinical Quality Measure Logic and Implementation Guidance document for a list of code system versions used in the eCQM specifications for 2020 reporting/performance. Measure Section: Terminology Source of Change: Standards Update Standardized purpose statement language in value sets across eCQMs. Value set purpose statements are visible in the Value Set Authority Center (VSAC) as well as the downloadable eCQM value set files. Measure Section: Terminology Source of Change: Measure Lead External Resources United States Health Information Knowledgebase NLM Value Set Authority Center (VSAC)